| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |